CompletedNot Applicable

A Clinical Study Carried Out in Patients Operated With Calcanail®

France84 participantsStarted 2022-08-01

Plain-language summary

This study is part of the Post-Market Clinical Follow-up process for the Calcanail medical device; the objective of which is to collect data on the safety and performance of the device after it has been placed on the market. The primary objective of this study is to evaluate the safety of the device. The secondary objectives are to evaluate the clinical performance and safety of the device. This is a research not involving the human person: observational study, retrospective, monocentric, non-comparative and national. 84 patients will be included in the study.

Who can participate

Age range19 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Patient operated with the studied device between the 01/01/2012 and 01/01/2020.
✓. Patient over 18 years old
✓. Patient who has received informed information and does not object to the collection of their data in this study.

What they're measuring

survival rate (revision)

Timeframe: 12 months

Trial details

NCT IDNCT06234358

SponsorFH ORTHO

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2022-09-01

View on ClinicalTrials.gov More Calcaneus Fracture trials